Chemicals giant BASF is reviewing strategic options for its subsidiary trinamiX GmbH as it sharpens its focus on core businesses under its new corporate strategy.

 

trinamiX, which specializes in biometric imaging and mobile material analysis, operates outside BASF’s strategic priorities. As a result, the group is reassessing the unit with an emphasis on restructuring, cost efficiency, and value optimization. The review could include the sale of individual business areas.

 

The strategic reset comes with a leadership change. Managing Director Ingmar Bruder, who guided trinamiX from its inception to its current stage, stepped down from the management board on January 26, 2026. He will be succeeded on February 1, 2026, by Lothar Laupichler, formerly head of BASF’s global electronic materials business. Sören Bauermann, a member of the trinamiX management team since 2023, will continue on the board.

 

Founded in 2015 as a BASF subsidiary, trinamiX develops solutions based on biometric imaging and mobile near-infrared (NIR) spectroscopy. Headquartered in Ludwigshafen, Germany, the company employs around 200 people worldwide and holds more than 800 patents and patent applications.